tirzepatide 60 units Forte Flex-Dose 4 mL Injectable 15 mg/mL Microdosing Tirzepatide Chart: A Weekly

The long-term benefits of glucose control on the eyes far outweigh any acute risk

Oral semaglutide is the only orally administered GLP-1 receptor agonist currently available and has been associated with reductions in glycated hemoglobin and body weight versus once-daily injectable liraglutide after 52 weeks in the PIONEER 4 clinical trial

About tirzepatide Tirzepatide is a once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that integrates the actions of both incretins into a single novel molecule

ACS Nano 14 (10), 1350013511

J Crohns Colitis (2020) 14:1693701

[74] Healthcare providers should counsel patients about these risks and consider dose modifications when combining melatonin with other sedating medications